Perrigo Announces Australian Approval for Generic Temozolomide
Perrigo Co. announced that it has received a final "Approval for Registration" letter from the Australian Therapeutic Goods Administration,permitting the company to sell generic temozolomide in Australia The letter also states that bioequivalence was met between the brand product, Temodar®, and the Company's generic temozolomide, enabling listing on the Pharmaceutical Benefits Scheme or PBS.
